Ultragenyx to Host Conference Call for Second Quarter 2021 Financial Results and Corporate Update
July 27 2021 - 5:00PM
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical
company focused on the development of novel therapies for serious
rare and ultra-rare genetic diseases, today announced that it will
host a conference call on Monday, August 2, 2021 at 5pm ET to
discuss its financial results and corporate update for the quarter
ended June 30, 2021.
The live and replayed webcast of the call will be available
through the company’s website
at https://ir.ultragenyx.com/events-presentations. To
participate in the live call by phone, dial (855) 797-6910 (USA) or
(262) 912-6260 (International) and enter the passcode 3654725. The
replay of the call will be available for one year.
About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing
novel therapies to patients for the treatment of serious rare and
ultra-rare genetic diseases. The company has built a diverse
portfolio of approved medicines and treatment candidates aimed at
addressing diseases with high unmet medical need and clear biology,
for which there are typically no approved therapies treating the
underlying disease.
The company is led by a management team experienced in the
development and commercialization of rare disease therapeutics.
Ultragenyx’s strategy is predicated upon time- and cost-efficient
drug development, with the goal of delivering safe and effective
therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company's
website at: www.ultragenyx.com
Contact Ultragenyx Pharmaceutical Inc.Investors &
MediaJoshua Higa415-475-6370
Ultragenyx Pharmaceutical (NASDAQ:RARE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ultragenyx Pharmaceutical (NASDAQ:RARE)
Historical Stock Chart
From Apr 2023 to Apr 2024